Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zi-Jin Weng

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Cell International|January 9, 2018
Collapsin response mediator protein 4 promotor methylation level as a potential predictor for diagnosing primary malignant lymphoma of the prostateZheng Chen, Qiong Liang, Jue Wang, et al.
Breast Cancer (Tokyo, Japan)|February 4, 2024
Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancerJie-Yin Zhuang, Ze-Nan Huang, Zi-Jin Weng, et al.
Annals of Clinical and Laboratory Science|October 5, 2022
The Prognostic Value of Microvascular Density in Early Postoperative Recurrence and Metastasis of T1 Esophageal Squamous Cell CarcinomaYi-Tai Xiao, Zi-Jin Weng, Rong-Wang Huang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 22, 2012
Prognostic significance of overexpression of EZH2 and H3k27me3 proteins in gastric cancerLong-Jun He, Mu-Yan Cai, Guo-Liang Xu, et al.
International Journal of Clinical Oncology|July 10, 2023
Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancerBo Wang, Meng Zhou, Xing-Li Gan, et al.
BMC Cancer|August 11, 2023
AGR2 and FOXA1 as prognostic markers in ER-positive breast cancerMeng Zhou, Xing-Li Gan, Yue-Xiang Ren, et al.
Clinical Epigenetics|October 28, 2022
Association of H3K9me3 with breast cancer prognosis by estrogen receptor statusMeng Zhou, Jin-Qi Yan, Qian-Xin Chen, et al.
Virchows Archiv : an International Journal of Pathology|September 25, 2021
Prognostic value of glutaminase 1 in breast cancer depends on H3K27me3 expression and menopausal statusMeng Zhou, Qian-Xin Chen, Yuan-Zhong Yang, et al.
Breast Cancer Research and Treatment|February 19, 2021
Time-varying effects of FOXA1 on breast cancer prognosisQian-Xin Chen, Yuan-Zhong Yang, Zhuo-Zhi Liang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Cell International|January 9, 2018
Collapsin response mediator protein 4 promotor methylation level as a potential predictor for diagnosing primary malignant lymphoma of the prostateZheng Chen, Qiong Liang, Jue Wang, et al.
Breast Cancer (Tokyo, Japan)|February 4, 2024
Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancerJie-Yin Zhuang, Ze-Nan Huang, Zi-Jin Weng, et al.
Annals of Clinical and Laboratory Science|October 5, 2022
The Prognostic Value of Microvascular Density in Early Postoperative Recurrence and Metastasis of T1 Esophageal Squamous Cell CarcinomaYi-Tai Xiao, Zi-Jin Weng, Rong-Wang Huang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 22, 2012
Prognostic significance of overexpression of EZH2 and H3k27me3 proteins in gastric cancerLong-Jun He, Mu-Yan Cai, Guo-Liang Xu, et al.
International Journal of Clinical Oncology|July 10, 2023
Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancerBo Wang, Meng Zhou, Xing-Li Gan, et al.
BMC Cancer|August 11, 2023
AGR2 and FOXA1 as prognostic markers in ER-positive breast cancerMeng Zhou, Xing-Li Gan, Yue-Xiang Ren, et al.
Clinical Epigenetics|October 28, 2022
Association of H3K9me3 with breast cancer prognosis by estrogen receptor statusMeng Zhou, Jin-Qi Yan, Qian-Xin Chen, et al.
Virchows Archiv : an International Journal of Pathology|September 25, 2021
Prognostic value of glutaminase 1 in breast cancer depends on H3K27me3 expression and menopausal statusMeng Zhou, Qian-Xin Chen, Yuan-Zhong Yang, et al.
Breast Cancer Research and Treatment|February 19, 2021
Time-varying effects of FOXA1 on breast cancer prognosisQian-Xin Chen, Yuan-Zhong Yang, Zhuo-Zhi Liang, et al.
Pageof 1